13F-HR filed by Integral Health Asset Management, LLC
Integral Health Asset Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 16:36:40 UTC, with 97 holding rows worth $1,647,277,325.
- Accession
- 0001172661-26-005192
- Filer
- CIK 1773206
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 97 entries on the cover page, a total value of $1,647,277,325 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,647,277,325 with VALUE read as dollars as filed, 13F file number 028-19946. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,000,000 | $130,340,100 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,600,000 | $128,978,200 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,400,000 | $97,440,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,600,000 | $72,501,000 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 450,000 | $65,389,500 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 1,255,000 | $60,641,600 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 750,000 | $46,590,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 250,000 | $46,097,500 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,500,000 | $32,290,000 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 75,000 | $31,613,250 | dollars as filed | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 2,600,000 | $31,278,000 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 40,000 | $30,330,800 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 90,000 | $23,000,400 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 100,000 | $22,588,000 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 1,000,000 | $22,455,000 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 100,000 | $22,250,000 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 500,000 | $21,422,500 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 150,000 | $21,276,000 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 40,000 | $20,912,400 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,700,000 | $20,205,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 300,000 | $19,740,000 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 160,000 | $19,416,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 500,000 | $19,030,000 | dollars as filed | |
| BRIGHTSPRING HEALTH SVCS | 10950A106 | COM | 325,000 | $18,443,750 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 50,000 | $18,297,000 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,000,000 | $18,285,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 470,000 | $18,038,600 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 100,000 | $17,900,000 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 400,000 | $17,460,000 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 200,000 | $17,264,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,130,000 | $16,565,800 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 375,000 | $15,195,000 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 175,000 | $15,100,750 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 90,000 | $14,777,100 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 120,000 | $14,578,800 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 100,000 | $14,257,000 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 1,300,000 | $14,001,000 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 55,000 | $12,818,850 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 500,000 | $12,765,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 25,000 | $12,599,000 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 200,000 | $12,480,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 300,000 | $12,180,000 | dollars as filed | call |
| UNIQURE NV | N90064101 | SHS | 500,000 | $12,080,000 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 250,000 | $11,901,875 | dollars as filed | |
| Teva Pharmaceutical Industries Ltd | M8769Q102 | Common / Ordinary Stock | 300,000 | $11,880,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 200,000 | $11,776,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 40,000 | $11,649,200 | dollars as filed | |
| LIVANOVA PLC | 53802LAB8 | NOTE 2.500% 3/1 | 150,000 | $11,475,000 | dollars as filed | |
| WATERS CORP COM | 941848103 | Stock | 25,000 | $10,984,750 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 325,000 | $10,458,500 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 150,000 | $10,404,000 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 400,000 | $10,052,000 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 455,000 | $9,950,850 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 14,000 | $9,450,700 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 1,200,000 | $9,036,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 325,000 | $8,903,000 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 3,500,000 | $8,715,000 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 150,000 | $8,479,500 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 700,000 | $8,029,000 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 450,000 | $7,713,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 30,000 | $7,402,200 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 240,000 | $7,137,600 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 40,000 | $7,134,400 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 125,000 | $6,972,500 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 150,000 | $6,697,500 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 350,000 | $6,678,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 200,000 | $6,404,000 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 70,000 | $6,325,200 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 500,000 | $6,145,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 690,000 | $6,058,200 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 2,000,000 | $5,830,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 460,000 | $5,722,400 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 200,000 | $5,564,000 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 700,000 | $5,173,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 50,000 | $4,951,000 | dollars as filed | |
| APNIMED INC | 03770Y107 | COM | 225,000 | $4,929,750 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 200,000 | $4,890,000 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,300,000 | $4,797,000 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 345,000 | $4,629,900 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 100,000 | $4,584,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 300,000 | $4,005,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 100,000 | $3,842,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,250,000 | $3,812,500 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 160,000 | $3,793,600 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 300,000 | $3,579,000 | dollars as filed | |
| KARDIGAN INC | 485925101 | CMN | 225,000 | $3,318,750 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 600,000 | $3,096,000 | dollars as filed | |
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 100,000 | $3,063,000 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 200,000 | $2,864,000 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 1,350,000 | $2,774,250 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 100,000 | $2,718,000 | dollars as filed | |
| AGOMAB THERAPEUTICS NV | 00860C102 | SPONSORED ADS | 235,000 | $2,608,500 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 200,000 | $2,250,000 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 100,000 | $2,020,000 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 495,000 | $1,999,800 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 200,000 | $1,052,000 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 250,000 | $725,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-005192 | this filing | 2026-11-16 |